References
1. Baigrie D, Bansal P, Goyal A, et al. Leukocytoclastic Vasculitis. [Updated 2020 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. 2. Cao S, Sun D. Leucocytoclastic vasculitis following influenza vaccination. BMJ case reports. 2017:bcr2016217755. 3. Monjazeb S, Philips RC, Wilkerson M. (2016A case of leukocytoclastic vasculitis following influenza vaccination. JAAD case reports. 2016;2(4):340–342. 4. Puram V, Lyon D, Skeik N. A Unique Case Report on Hypersensitivity Vasculitis as an Allergic Reaction to the Herpes Zoster Vaccine.Vasc Endovascular Surg. 2019;53(1):75-78. 5. McLean H, Fiebelkorn A, Temte J, Wallace, G. Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62:1-34. 6. Anbarasu A, Ramaiah S, Livingstone P. Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality? Human Vaccines & Immunotherapeutics. 2020;16(9):2217-2218. 7. Da Dalt L, Zerbinati C, Strafella, MS, Renna S, Riceputi L, Di Pietro P, Barabino P, Scanferla S, Raucci U, Mores N, Compagnone A, Da Cas R, Menniti-Ippolito F. Henoch-Schönlein purpura and drug and vaccine use in childhood: a case-control study. Italian journal of pediatrics. 2016;42(1):60. 8. Binamer Y. Acute hemorrhagic edema of infancy after MMR vaccine.Ann Saudi Med. 2015;35(3):254-256. 9. Sedaghat M, Zarei-Ghanavati S, Shokoohi S, Ghasemi A. Panuveitis and dermal vasculitis following MMR vaccination. East Mediterr Health J. 2007;13(2):470-4. 10. Loree, Jonathan M., et al. ”Leukocytoclastic vasculitis following lenalidomide during the treatment of follicular lymphoma.”Leukemia & Lymphoma 58.3 (2017): 711-714.